175 related articles for article (PubMed ID: 34198593)
1. Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma.
Yoshida Y; Yoshio S; Yamazoe T; Mori T; Tsustui Y; Kawai H; Yoshikawa S; Fukuhara T; Okamoto T; Ono Y; Takahashi Y; Hashida R; Kawaguchi T; Taketomi A; Kanto T
Cells; 2021 Jun; 10(6):. PubMed ID: 34198593
[TBL] [Abstract][Full Text] [Related]
2. Increased Frequency of Dysfunctional Siglec-7
Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
Front Immunol; 2021; 12():603133. PubMed ID: 33692781
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma.
Sakata T; Yoshio S; Yamazoe T; Mori T; Kakazu E; Aoki Y; Aoyanagi N; Okamoto T; Ito T; Toyoda H; Kawaguchi T; Ono Y; Takahashi Y; Taketomi A; Kanto T
Front Immunol; 2024; 15():1389411. PubMed ID: 38638429
[TBL] [Abstract][Full Text] [Related]
4. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
[TBL] [Abstract][Full Text] [Related]
5. Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
Xiao R; Tian Y; Zhang J; Li N; Qi M; Liu L; Wang J; Li Z; Zhang J; Zhao F; Wang T; Tan S; Li C; Wu Z; Yu M; Jiang X; Zhan P; Gao L; Han B; Liu X; Liang X; Ma C
J Hepatol; 2024 May; 80(5):792-804. PubMed ID: 38331327
[TBL] [Abstract][Full Text] [Related]
6. Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
Tao L; Wang S; Yang L; Jiang L; Li J; Wang X
Clin Exp Immunol; 2020 Aug; 201(2):161-170. PubMed ID: 32319079
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of Tumor-Infiltrating CD49a
Sun H; Liu L; Huang Q; Liu H; Huang M; Wang J; Wen H; Lin R; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
Cancer Immunol Res; 2019 Sep; 7(9):1535-1546. PubMed ID: 31311791
[TBL] [Abstract][Full Text] [Related]
8. Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma.
Zecca A; Barili V; Rizzo D; Olivani A; Biasini E; Laccabue D; Dalla Valle R; Ferrari C; Cariani E; Missale G
Cells; 2021 Mar; 10(3):. PubMed ID: 33802077
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.
Hu J; Wang E; Liu L; Wang Q; Xia D; Bai W; Tie J; Li X; Yuan J; Yang S; Jiang D; Shi J; Sun Y; Wang J; Zhang C; Niu J; Li K; He C; Guo W; Lv Y; Chen H; Yuan X; Yu T; Wang Z; Luo B; Han N; Zhu Y; Yin Z; Fan D; Zhang Z; Yang K; Han G
Invest New Drugs; 2020 Oct; 38(5):1247-1256. PubMed ID: 31832851
[TBL] [Abstract][Full Text] [Related]
10. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma.
Zhang P; Lu X; Tao K; Shi L; Li W; Wang G; Wu K
J Surg Res; 2015 Mar; 194(1):107-13. PubMed ID: 25450598
[TBL] [Abstract][Full Text] [Related]
11. Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma.
Fathy A; Eldin MM; Metwally L; Eida M; Abdel-Rehim M
Egypt J Immunol; 2009; 16(2):17-25. PubMed ID: 22059350
[TBL] [Abstract][Full Text] [Related]
12. [Reduced frequency of natural killer cell on siglec-7(+) is associated with progression of hepatitis B virus-related cirrhosis].
Li YL; Zhang QF; Yin WW; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):420-425. PubMed ID: 30317754
[No Abstract] [Full Text] [Related]
13. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
14. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
[TBL] [Abstract][Full Text] [Related]
15. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.
Hamann I; Unterwalder N; Cardona AE; Meisel C; Zipp F; Ransohoff RM; Infante-Duarte C
Immunology; 2011 May; 133(1):62-73. PubMed ID: 21320123
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of Human Hepatic Intrasinusoidal CD56
Hwang S; Han J; Baek JS; Tak E; Song GW; Lee SG; Jung DH; Park GC; Ahn CS; Kim N
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925759
[TBL] [Abstract][Full Text] [Related]
17. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
Bonorino P; Ramzan M; Camous X; Dufeu-Duchesne T; Thélu MA; Sturm N; Dariz A; Guillermet C; Pernollet M; Zarski JP; Marche PN; Leroy V; Jouvin-Marche E
J Hepatol; 2009 Sep; 51(3):458-67. PubMed ID: 19596474
[TBL] [Abstract][Full Text] [Related]
18. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
[TBL] [Abstract][Full Text] [Related]
19. Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing.
Liu H; Zhao R; Qin R; Sun H; Huang Q; Liu L; Tian Z; Nashan B; Sun C; Sun R
Cancer Biol Med; 2022 Jul; 19(9):1334-51. PubMed ID: 35856557
[TBL] [Abstract][Full Text] [Related]
20. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.
Hudspeth K; Donadon M; Cimino M; Pontarini E; Tentorio P; Preti M; Hong M; Bertoletti A; Bicciato S; Invernizzi P; Lugli E; Torzilli G; Gershwin ME; Mavilio D
J Autoimmun; 2016 Jan; 66():40-50. PubMed ID: 26330348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
